BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2008
View Archived Issues
Effects of INO-8875 on atrioventricular nodal conduction shown in rats
Read More
Enhanced lipid effects seen with ezetimibe/simvastatin plus niacin in hyperlipidemia
Read More
BTG presents an update on the company's clinical development programs
Read More
Satoris enters collaboration with Mayo Clinic to validate early Alzheimer's test
Read More
Dr. Reddy's signs definitive agreement to acquire portion of Dowpharma Small
Read More
EMEA approves Forsteo for treatment of glucocorticoid-induced osteoporosis
Read More
FDA approves Rotarix, a pediatric rotavirus vaccine
Read More
Recent patents impart novel metabolic drugs
Read More
AZD-1480, a novel JAK2 inhibitor profiled at AstraZeneca
Read More
Efficacy of radiotherapy enhanced by SPI-1620
Read More
GenVec receives USD 600,000 grant from NIH for malaria vaccine program
Read More
Recent patents disclose novel therapeutic agents for inflammatory disorders
Read More
EntreMed initiates phase I clinical trial of MKC-1 in metastatic solid tumors
Read More
Recent patents describe new treatment options for respiratory disorders
Read More
Alfacell reports evaluable events from phase IIIb clinical trial of Onconase
Read More
Radius completes enrollment in phase II clinical trial of BA-058 for osteoporosis
Read More
PharmAthene acquires Avecia's biodefense vaccines business
Read More
ActivBiotics sells intellectual property assets for USD 3.5 million
Read More
CG Therapeutics and the University of Washington to develop human monoclonal antibodies
Read More
Vical receives USD 2.0 million NIH grant for immunotherapeutic herpes DNA vaccine
Read More
EMEA grants orphan drug designation to Tengion for Neo-Bladder Augment for spina bifida
Read More
Preclinical profile of Merck's novel HCV protease inhibitor reported at the ACS meeting
Read More
EpiCept reports positive clinical data from phase I EPC-2407 trial
Read More
